Insider · CIK 0001432241

OrbiMed Capital GP III LLC

CIK 0001432241 Name as filed on the most recent filing

Filed as OrbiMed Capital GP III LLC (56)

265 transaction lines · from 56 filings · filed 2011-02-10 to 2018-08-21 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2015-07-06 P, Open-market purchase Pieris Pharmaceuticals, Inc.PIRS 2 lines 1,375,000, acquired Open Form 4 filing 0000899243-15-000922
2014-07-22 P, Open-market purchase Roka BioScience, Inc.ROKA 2 lines 4,599,996, acquired Open Form 4 filing 0001140361-14-029280
2013-11-07 P, Open-market purchase Response Biomedical CorpRBM 3 lines 1,999,996, acquired Open Form 4 filing 0001209191-13-051769
2013-05-23 P, Open-market purchase Ambit Biosciences CorpAMBI 2 lines 87,366, acquired Open Form 4 filing 0001140361-13-022813
2013-05-22 P, Open-market purchase Ambit Biosciences CorpAMBI 2 lines 146,139, acquired Open Form 4 filing 0001140361-13-022813
2013-05-21 P, Open-market purchase Ambit Biosciences CorpAMBI 6 lines 5,350,034, acquired Open Form 4 filing 0001140361-13-022344
2013-05-20 P, Open-market purchase Ambit Biosciences CorpAMBI 2 lines 71,839, acquired Open Form 4 filing 0001140361-13-022344
2012-09-04 S, Open-market sale Amarin Corp Plc\UkAMRN 2 lines 3,372,992, disposed Open Form 4 filing 0000947871-12-000627
2012-07-27 S, Open-market sale Amarin Corp Plc\UkAMRN 2 lines 5,350,691, disposed Open Form 4 filing 0000947871-12-000570
2012-07-13 S, Open-market sale Complete Genomics IncGNOM 2 lines 1,203,331, disposed Open Form 4 filing 0000947871-12-000539
2012-07-12 S, Open-market sale Complete Genomics IncGNOM 2 lines 628,907, disposed Open Form 4 filing 0000947871-12-000539
2012-07-11 S, Open-market sale Complete Genomics IncGNOM 2 lines 1,472,405, disposed Open Form 4 filing 0000947871-12-000539
2012-06-19 S, Open-market sale Amarin Corp Plc\UkAMRN 2 lines 7,968,427, disposed Open Form 4 filing 0000947871-12-000493
2012-03-12 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 2 lines 696,107, disposed Open Form 4 filing 0001104659-12-017959
2012-03-09 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 2 lines 416,087, disposed Open Form 4 filing 0001104659-12-017959
2012-02-29 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 32,584, disposed Open Form 4 filing 0001104659-12-014732
2012-02-28 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 2 lines 112,316, disposed Open Form 4 filing 0001104659-12-014732
2012-02-27 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 2 lines 320,369, disposed Open Form 4 filing 0001104659-12-014732
2012-02-03 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 2 lines 539,520, disposed Open Form 4 filing 0001104659-12-006674
2012-02-02 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 2 lines 252,917, disposed Open Form 4 filing 0001104659-12-006674
2012-02-01 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 2 lines 770,406, disposed Open Form 4 filing 0001104659-12-006674
2011-10-31 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 2 lines 1,025,635, disposed Open Form 4 filing 0001104659-11-060216
2011-05-02 S, Open-market sale Amarin Corp Plc\UkAMRN 2 lines 536,270, disposed Open Form 4 filing 0000947871-11-000463

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. OrbiMed Capital GP III LLC, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001432241

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.